SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob Swift who wrote (1863)3/2/1999 12:18:00 PM
From: David Howe  Read Replies (2) of 10280
 
<< Will Lilly and SGP continue to push the ICE ? If it is not better, will consumers pay up ? >>

They have no choice. Their patents are expiring and they will use their partnership with SEPR to extend their sales for another 15 - 20 years. They push SEPR's ICE or they push nothing at all.

<< WHAT IF no one cares about a half-way better mouse trap" question. >>

Most drugs today are racemates (a 1:1 mixture of 2 isomers). Isomers are molecules that are non-superimposable mirror images of one another, much like right and left hands. In fact racemic drugs are called chiral drugs, from the Greek language, meaning "handedness". The two isomers are termed R and S. (from the SEPR web site)

One isomer is there because it has a therapeutic effect. The other isomer that doesn't serve a therapeutic purpose is just along for the ride. It can float around your body and do whatever it wants (side effects).

SEPR eliminates the unnecessary "hand".

Now, if I'm choosing a drug, do I choose the pure one, or the one that has a hitchhiker along that plans to raise hell with my body?

I choose the pure one, the ICE.

Dave
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext